12
Participants
Start Date
October 25, 2021
Primary Completion Date
August 20, 2025
Study Completion Date
June 30, 2026
HST-NEETs
HST-NEETs are manufactured from an autologous peripheral blood or MNCs via apheresis collection and will be administered as a single intravenous (IV) infusion of 2x10\^7/m\^2 cells between 3 Days and 7 Days post-ASCT.
Bone Marrow Transplant
Day 0 is the day of bone marrow transplantation.
Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering (MSKCC), New York
University of Pennsylvania, Philadelphia
Georgetown, Washington D.C.
Johns Hopkins University, Baltimore
Northside, Atlanta
H. Lee Moffitt Cancer Center, Tampa
University of Illinois, Chicago
Baylor College of Medicine, Houston
MD Anderson, Houston
City of Hope National Medical Center, Duarte
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Blood and Marrow Transplant Clinical Trials Network
NETWORK
National Cancer Institute (NCI)
NIH
National Marrow Donor Program
OTHER
Children's National Research Institute
OTHER
Catherine Bollard
NIH